Cutler Group LP Sangamo Therapeutics, Inc Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$2.77 - $5.07 $1,656 - $3,031	-598 Reduced 46.07%	700 $2,000
Q3 2022 Oct 25, 2022	BUY	$4.27 - $6.39 $5,542 - $8,294	1,298 New	1,298 $6,000
Q1 2019 May 10, 2019	SELL	$7.72 - $12.81 $9,696 - $16,089	-1,256 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$16.7 - $26.35 $20,975 - $33,095	1,256 New	1,256 $23,000

109

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.